ClinicalTrials.Veeva

Menu

Triple Antibiotic Paste vs Simvastatin for Lesion Sterilization and Tissue Repair in Primary Molars. (LSTR)

D

Dow University of Health Sciences

Status and phase

Enrolling
Phase 2

Conditions

Pulpal Necrosis

Treatments

Combination Product: Lesion Sterilization and Tissue Repair

Study type

Interventional

Funder types

Other

Identifiers

NCT07264842
3379/DUHS//Approval/2024/175

Details and patient eligibility

About

This randomized, double-blinded, parallel-controlled clinical trial aims to compare the effectiveness of Triple Antibiotic Paste (TAP) and Simvastatin in Lesion Sterilization and Tissue Repair (LSTR) of primary molars with pulp necrosis.

A total of 60 children (aged 5-8 years) with non-vital primary molars will be recruited from the Department of Operative Dentistry and Endodontics, Dow International Dental College, Karachi. Participants will be randomly assigned to one of two groups:

Group 1 (Control): LSTR using Triple Antibiotic Paste (Ciprofloxacin + Metronidazole + Cefixime).

Group 2 (Intervention): LSTR using Simvastatin paste.

Both materials will be placed after non-instrumentation cleaning and sealed with glass ionomer cement, followed by stainless steel crown placement. Patients will be evaluated clinically and radiographically at 1, 2, and 3 months post-treatment.

Primary outcomes include clinical success (absence of pain, swelling, or sinus tract) and radiographic success (reduction or absence of periapical radiolucency). Data will be analyzed using SPSS v26, with chi-square and t-tests applied as appropriate; p < 0.05 will be considered significant.

This study seeks to determine whether Simvastatin, owing to its antibacterial, anti-inflammatory, and regenerative properties, can serve as a viable alternative to antibiotic-based LSTR in managing necrotic primary teeth.

Enrollment

60 estimated patients

Sex

All

Ages

5 to 8 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Young, healthy patient, ranging in age from 5-8 years.

  • Has parents/ guardians who give consent to allow their minor to participate in the study and willing to monitor their progress.

  • Having maxillary and mandibular primary molars with:

    • Spontaneous pain or tenderness to percussion.
    • Deep cavity extending to the pulp chamber.
    • Chronic Abscess or draining sinus.
    • Restorable.
    • To be kept for less than a year.
    • Irregular mobility that is not related to exfoliation.

Exclusion criteria

  • Uncooperative patients.
  • Children with a history of allergic reaction with antibiotics.
  • Teeth with physiological root resorption but root length is more than two thirds, root canal obliteration, severe internal resorption, internal calcifications, or piercing into the bifurcation.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups

Simvastatin
Experimental group
Description:
Lesion Sterilization and Tissue Repair using Simvastatin.
Treatment:
Combination Product: Lesion Sterilization and Tissue Repair
Triple Antibiotic Paste
Active Comparator group
Description:
Lesion Sterilization and Tissue Repair using triple antibiotic paste
Treatment:
Combination Product: Lesion Sterilization and Tissue Repair

Trial contacts and locations

1

Loading...

Central trial contact

Prof. Dr. Farah Naz Supervisor, FCPS; Muhammad Waleed Postgraduate Trainee, FCPS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems